Accessibility Menu
Immunotech Laboratories logo

Immunotech Laboratories

(OTC) IMMB

Current Price$0.00
Market Cap$115.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-93%
1 Year+100%
1 Month+0%

Immunotech Laboratories Financials at a Glance

Market Cap

$115.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$640.25K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$0.00

Volume

110,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

IMMB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immunotech Laboratories

Industry

Biotechnology

Headquarters

Monrovia, CA 91016, US

IMMB Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-9.01%

Return on Capital

-6.52%

Return on Assets

-4.68%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$115.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

574.97M

Volume

110.00K

Avg. Volume

7.38K

Financials (TTM)

Gross Profit

-$229.16K

Operating Income

-$486.04K

EBITDA

-$473.44K

Operating Cash Flow

-$301.21K

Capital Expenditure

-$113.00K

Free Cash Flow

-$418.18K

Cash & ST Invst.

$14.29K

Total Debt

$2.42M

Immunotech Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2016YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$76.39K

N/A

Gross Margin

0.00%

N/A

Market Cap

$115.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$28.75K

N/A

Employees

4

N/A

Net Income

-$119.60K

-27.2%

EBITDA

-$109.85K

+86.2%

Quarterly Fundamentals

Name
Q4 2016YOY CHG

Total Cash

$14.29K

-2.4%

Total Debt

$2.42M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

-100.0%

Long Term Debt

$1.65M

N/A

Short Term Debt

$772.89K

N/A

Return on Assets

-4.68%

N/A

Return on Invested Capital

-7.30%

N/A

Free Cash Flow

-$181.47K

-54.4%

Operating Cash Flow

-$68.47K

+38.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CBGLCannabis Global Inc.
$0.00+0.00%
BIOIFBiome Grow Inc.
$0.00+0.00%
REFGMedical Cannabis Payment Solutions
$0.00+0.00%
HADVHealth Advance Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
FRMIFermi
$6.59-0.10%
INTCIntel
$109.84-0.02%
ONDSOndas
$7.26-0.05%
NOKNokia
$12.44-0.04%

Questions About IMMB

What is the current price of Immunotech Laboratories?

Immunotech Laboratories is trading at $0.00 per share.

What is the 52-week range for Immunotech Laboratories?

Over the past 52 weeks, Immunotech Laboratories has traded between $0.00 and $0.00.

How much debt does Immunotech Laboratories have?

Immunotech Laboratories total debt is unavailable.

How much cash does Immunotech Laboratories have on hand?

Immunotech Laboratories does not have cash on hand data available.

What is Immunotech Laboratories’s dividend yield?

Immunotech Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.